Home/Subjects/Drug Delivery Systems
Drug Delivery Systems Expertise for Research, Regulatory and Scientific Communication
Pubrica provides drug delivery expertise across research, regulatory documentation, scientific writing, publication, publisher services, data analysis and digital communication. We support academic institutions, pharmaceutical science departments, pharmaceutical and biotechnology companies, formulation and contract development organisations, combination product developers, journals and publishers.
Projects are matched with specialists according to the delivery system, study design, analytical methods and intended use of the work, including formulation development, nanoparticle and liposomal systems, in vitro release testing, pharmacokinetic studies, targeting and biodistribution work and in vitro to in vivo correlation. Depending on the study, we assess release conditions and sink conditions, physicochemical characterisation, stability and the evidence for in vivo relevance so that findings are well supported.
Specialists are assigned by topic, study design and methods.
Services
Drug Delivery Systems Expertise Across Our Services
Each service area below applies to drug delivery work. The assigned team combines the drug delivery expertise with the skills that the deliverable requires.
1PUBLISHING IN JOURNALS
Research servicesResearch questions, formulation and release study design, protocols, evidence synthesis and methodological review for drug delivery research. Editing & translationScientific editing, pharmaceutical terminology review, proofreading and translation of drug delivery manuscripts and documents. Publication supportJournal selection, manuscript preparation, submission support and responses to reviewers for pharmaceutics and drug delivery journals. Research impactPlain-language summaries, graphical abstracts, research news and dissemination materials for drug delivery research. Physician writingClinical manuscripts and reviews where drug delivery technologies are evaluated in patients, prepared with or for clinicians. All publishing in journals services2SUBMITTING TO REGULATORS
Discovery & intelligenceTechnology landscape assessments of delivery platforms, patent and literature reviews, and research gap analysis. Medical & scientific writingResearch reports, manuscripts, formulation development reports and scientific components of pharmaceutical dossiers. Medical communicationsScientific presentations, publication content and professional education on drug delivery technologies and their clinical use. Regulatory writingPharmaceutical development and quality sections of submissions, nonclinical summaries and related documentation for delivery systems. Medical device & IVDEvidence and documentation for drug–device combination products and delivery devices, according to intended use and jurisdiction. Market access & HEOREvidence synthesis and value assessments where a delivery technology changes adherence, dosing or clinical outcomes. All submitting to regulators services3EDITORIAL SUPPORT FOR PUBLISHERS
Editorial & journal servicesSubject-specific manuscript assessment, methods review and editorial quality checks for pharmaceutics journals. AccessibilityAccessible presentation of drug delivery documents, figures, schematics, tables and educational materials for varied audiences. Education & assessmentPharmaceutics and drug delivery learning materials, curricula, question banks and professional training content. All editorial support for publishers servicesStudy types
Study Types We Support
Drug delivery projects require expertise in both the pharmaceutical question and the methods used to investigate it. Specialists are assigned according to the research objectives, experimental design, analytical approach and deliverables.
Methodological review
Scientific and Methodological Review
The review approach reflects the project. For regulatory applications we also consider pharmaceutical development, quality attributes, stability and the strength of nonclinical and clinical evidence, as applicable.
Research services
Drug Delivery Systems Research Services in Detail
Support is available for individual tasks or across several stages of a project. The agreed scope defines the services, deliverables and specialist input required.
Who we support
Who We Support
Reporting standards
Reporting Guidelines and Publication Standards
Applicable guidelines are identified according to the study design, target journal and intended deliverable. The scope of work specifies the standards and checklists relevant to your project.
Standards applied according to the study and the deliverable
Animal ethics approval and data availability are checked against journal and funder requirements. Pharmaceutical quality, nonclinical and combination product regulations are applied where the deliverable calls for them.
Responsible use of AI
Responsible Use of AI
Any proposed use of AI tools is considered against the agreed scope, confidentiality requirements and the relevant institutional or journal policies.
Process
How Our Service Works
For interdisciplinary projects, specialists from the relevant fields may work together. If suitable expertise is not available, we say so during the assessment.
Our team
Our Drug Delivery Systems Support Team
The team is selected according to the services required. Interdisciplinary assignments combine the relevant expertise, with responsibilities defined for each contributor.
Roles assigned according to the services required
Sample work
Sample Work
Examples of research and publication deliverables, including methodological documentation, search strategies, analytical outputs and scientific figures. Client materials are shared only with permission and are anonymised or redacted where required.
Benefits
Benefits of Specialist Support
Scope and pricing
Project Scope and Pricing
Pricing reflects the complexity of the research, the services required and the agreed deliverables.
FAQs
Drug Delivery Systems FAQs
Assignment considers the delivery system, study design and methods. We assess the expertise required before confirming the project.
It depends on the study design. Animal studies may require ARRIVE 2.0, nanomaterial studies may use MIRIBEL, clinical trials CONSORT 2025, and development and stability work is often written against ICH Q8(R2) and Q1A(R2). Journal-specific requirements are also reviewed.
Depending on the study, we assess release and sink conditions, physicochemical characterisation, batch reproducibility, stability, animal study design, in vitro to in vivo relevance and the strength of the conclusions.
Yes. Release kinetics modelling, pharmacokinetic analysis and statistical support can be included in the scope, subject to the data, the research objectives and the expertise required.
Yes. Regulatory writing covers pharmaceutical development, quality and nonclinical documentation, and medical device support covers drug–device combination products, according to intended use and jurisdiction.
We assess whether specialists from more than one discipline are needed and define their responsibilities within the project.
Authorship depends on the contributions made and the applicable journal criteria. Editorial, analytical or writing assistance is disclosed or acknowledged as required.
Discuss Your Drug Delivery Systems Project
Share your research question, product, document or communication objective. We will assess the expertise required and propose the deliverables, timeline and scope of work.